Randomized trials have shown that selective serotonin reuptake inhibitors (SSRIs) and
serotonin-norepinephrine reuptake inhibitors (SNRIs) have better safety profiles than classical …

Despite numerous antidepressants available, many patients with depression do not achieve
adequate response rendering needs for novel antidepressants with different mechanism of …

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to
huge impacts on direct and indirect personal and public medical costs. To overcome such a …

Comorbid psychiatric disorders in adults with ADHD are important because these comorbidities
might complicate the diagnosis of ADHD and also worsen the prognosis. However, the …

Multi-label brain segmentation from brain magnetic resonance imaging (MRI) provides valuable
structural information for most neurological analyses. Due to the complexity of the brain …

Less than one third of patients who suffer from major depressive disorder (MDD) report
remission following antidepressant treatments requiring more diverse treatment approaches. …

This study compared demographical and clinical variables between first and multiple suicide
attempters and investigated risk and protective factors predicting multiple attempts. 228 …

The relative positions of the sun, moon, and earth, their movements, and their relationships
are abstract and difficult to understand astronomical concepts in elementary school science. …

Background: Vortioxetine was approved by the US Food and Drug Administration (FDA) in
September 2013 for treating major depressive disorder (MDD). Thus far, a number of …

Vortioxetine has a beneficial pharmacological profile for reducing anxiety and depression.
Recently, a number of randomized, double-blind, placebo-controlled clinical trials (RCTs) of …